Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression <i>in vivo</i>.

iScience · 2023 · PMC10250830 · PMID 37305702

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the intermediate responder xenograft (PDAC012T), the mice treated with the combination showed a higher tumor growth inhibition compared with the chemotherapy alone, even if it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.